| Date Filed | Type | Description |
| 03/07/2023 |
4
| Fox Jonathan C (Director) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 43,731 options to buy
@ $9.43, valued at
$412.4k
|
|
| 03/07/2023 |
3
| Fox Jonathan C (Director) has filed a Form 3 on Edgewise Therapeutics, Inc. |
| 01/28/2021 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Gifted 500 shares
@ $0
Unknown transaction of 380,467 shares
@ $0
Disposed/sold 70,000 options to buy
@ $13.2, valued at
$924k
|
|
| 09/18/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,767 shares
@ $50.1576, valued at
$289.3k
|
|
| 09/16/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 111 shares
@ $50, valued at
$5.6k
Sold 1,000 shares
@ $50.064, valued at
$50.1k
Sold 3,122 shares
@ $50.1632, valued at
$156.6k
|
|
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 444 shares
@ $41.5735, valued at
$18.5k
Gifted 1,020 shares
@ $0
Gifted 1,020 shares
@ $0
Sold 5,000 shares
@ $50, valued at
$250k
|
|
| 06/01/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $50, valued at
$250k
|
|
| 04/27/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,847 shares
@ $50, valued at
$142.4k
Sold 2,153 shares
@ $50, valued at
$107.7k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 6,420 shares
@ $55.0112, valued at
$353.2k
Sold 3,580 shares
@ $55, valued at
$196.9k
|
|
| 01/09/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Gifted 170 shares
@ $0
Gifted 100 shares
@ $0 |
|
| 12/05/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Gifted 1,000 shares
@ $0
Sold 10,000 shares
@ $58.9048, valued at
$589k
|
|
| 11/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 4,998 shares
@ $36.1633, valued at
$180.7k
Sold 2 shares
@ $36.71, valued at
$73.4 |
|
| 09/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,220 shares
@ $38.3561, valued at
$85.2k
Sold 2,780 shares
@ $39.0091, valued at
$108.4k
|
|
| 07/17/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 1,769 shares
@ $12.0105, valued at
$21.2k
Sold 15,000 shares
@ $40.0374, valued at
$600.6k
|
|
| 05/31/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $32.6357, valued at
$163.2k
|
|
| 05/06/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $25.03, valued at
$125.2k
|
|
| 05/03/2019 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 1,081 shares
@ $12.01, valued at
$13k
Sold 1,108 shares
@ $26.01, valued at
$28.8k
Sold 3,892 shares
@ $25.3, valued at
$98.5k
|
|
| 04/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2018 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 70,000 options to buy
@ $13.2, valued at
$924k
|
|
| 06/19/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |